Drug profile · INN
epoetin theta
EPORATIO
epoetin theta (EPORATIO) is a erythropoietin receptor agonist. Associated with Teva Pharma GmbH.
EMA: approved Blood and blood forming organs (B03) B03XA01
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — epoetin theta
- Class
- Blood and blood forming organs (B03)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
epoetin theta (EPORATIO) is a erythropoietin receptor agonist. Associated with Teva Pharma GmbH.
Key facts
INN epoetin theta
Brand EPORATIO
Mechanism Erythropoietin receptor agonist
Target Erythropoietin receptor
Therapeutic class Blood and blood forming organs (B03)
ATC code B03XA01
Originator Teva Pharma GmbH
Mechanism of action
Erythropoietin receptor agonist
Primary target: Erythropoietin receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is epoetin theta?
epoetin theta (EPORATIO) is a erythropoietin receptor agonist. Associated with Teva Pharma GmbH.
What is the brand name for epoetin theta?
EPORATIO is a marketed brand name for epoetin theta. Check FDA Drugs@FDA for the current US label holder and prescribing information.